Healthcare provider profile · identity verified

Robert J Havey, MD

Internal Medicine · CHICAGO, IL · NPI 1780677211

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1039	283
Amlodipine Besylate	Amlodipine Besylate	682	200
Rosuvastatin Calcium	Rosuvastatin Calcium	678	195
Metoprolol Succinate	Metoprolol Succinate	618	174
Losartan Potassium	Losartan Potassium	538	157
Levothyroxine Sodium	Levothyroxine Sodium	530	136
Irbesartan	Irbesartan	344	105
Hydrochlorothiazide	Hydrochlorothiazide	340	105
Eliquis	Apixaban	339	74
Ezetimibe	Ezetimibe	292	96
Allopurinol	Allopurinol	270	73
Potassium Chloride	Potassium Chloride	261	79
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	240	75
Ozempic	Semaglutide	233	34
Spironolactone	Spironolactone	177	55
Tamsulosin Hcl	Tamsulosin Hcl	177	56
Metformin Hcl Er	Metformin Hcl	175	54
Carvedilol	Carvedilol	158	40
Simvastatin	Simvastatin	134	35
Omeprazole	Omeprazole	132	39
Torsemide	Torsemide	129	43
Alprazolam	Alprazolam	128	29
Jardiance	Empagliflozin	128	40
Zolpidem Tartrate	Zolpidem Tartrate	128	40
Lisinopril	Lisinopril	118	30
Repatha Sureclick	Evolocumab	117	16
Synthroid	Levothyroxine Sodium	117	31
Sertraline Hcl	Sertraline Hcl	110	30
Escitalopram Oxalate	Escitalopram Oxalate	109	35
Clonazepam	Clonazepam	105	19
Pantoprazole Sodium	Pantoprazole Sodium	102	31
Valacyclovir	Valacyclovir Hcl	102	40
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	95	29
Lorazepam	Lorazepam	94	22
Pravastatin Sodium	Pravastatin Sodium	94	29
Gabapentin	Gabapentin	89	30
Amiodarone Hcl	Amiodarone Hcl	85	22
Furosemide	Furosemide	85	26
Metformin Hcl	Metformin Hcl	85	26
Mounjaro	Tirzepatide	84	13
Prednisone	Prednisone	81	50
Finasteride	Finasteride	78	20
Clopidogrel	Clopidogrel Bisulfate	76	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	72	41
Esomeprazole Magnesium	Esomeprazole Magnesium	67	19
Metoprolol Tartrate	Metoprolol Tartrate	65	17
Paxlovid	Nirmatrelvir/Ritonavir	65	64
Citalopram Hbr	Citalopram Hydrobromide	62	17
Atenolol	Atenolol	57	16
Estradiol (Twice Weekly)	Estradiol	57	14
Xarelto	Rivaroxaban	56	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	41
Belsomra	Suvorexant	50	suppressed
Montelukast Sodium	Montelukast Sodium	50	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	15
Glimepiride	Glimepiride	47	15
Ramipril	Ramipril	46	14
Myrbetriq	Mirabegron	45	12
Celecoxib	Celecoxib	41	12
Fluoxetine Hcl	Fluoxetine Hcl	39	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Estradiol	Estradiol	36	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Colesevelam Hcl	Colesevelam Hcl	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	29	14
Azithromycin	Azithromycin	29	26
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Rizatriptan	Rizatriptan Benzoate	27	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Diazepam	Diazepam	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	24	suppressed
Praluent Pen	Alirocumab	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Forteo	Teriparatide	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Famotidine	Famotidine	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	11
Alfuzosin Hcl Er	Alfuzosin Hcl	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Livalo	Pitavastatin Calcium	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Amoxicillin	Amoxicillin	18	14
Chlorthalidone	Chlorthalidone	18	suppressed
Potassium Citrate Er	Potassium Citrate	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Klor-Con M10	Potassium Chloride	17	suppressed
Methimazole	Methimazole	17	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Hydroxyurea	Hydroxyurea	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Lipitor	Atorvastatin Calcium	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Linzess	Linaclotide	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Progesterone	Progesterone, Micronized	13	suppressed
Topiramate	Topiramate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error